Richard M. Mueller

Rich Mueller oversees the innovation, development and research of TransEnterix’s revolutionary and evolutionary technologies for minimally invasive surgery.

A biomechanical engineer, Mueller most recently served as vice president of product development at NuVasive Inc., a publicly traded spinal device company whose rapid growth was fueled by product innovations. Previously, he was director of research and product development at Theken Spine, a start up later acquired by Integra Life Sciences.

With more than 100 medical device launches under his belt, Mueller effectively engages surgeons and advances solutions that make their work easier and result in better patient care.

Tammy Barnes Carrea

Tammy Barnes Carrea has more than 20 years of experience managing quality and regulatory affairs within the medical-device industry. Her responsibilities include operational- and manufacturing-related compliance, U.S. and international market clearance and post-market regulation.

Previously, Carrea worked with Sicel Technologies, a start-up firm for implantable medical sensors. She also managed regulatory and quality affairs for new product development at Pharmanetics, a coagulation and drug monitoring diagnostics firm.

Carrea holds a bachelor’s of science degree in engineering from North Carolina State University. A member of the Regulatory Affairs Professional Society, she is a certified regulatory affairs professional.

Janet Jamiolkowski

Responsible for the financial management of TransEnterix, Janet Jamiolkowski has more than 20 years of executive and financial experience with pharmaceutical and information technology companies.

Prior to joining TransEnterix, Jamiolkowski served as vice president of finance for Etrials Worldwide Inc., a publicly traded company offering software solutions for managing clinical trials. While there, she assisted the company's sale to Merge Healthcare.

Jamiolkowski previously served in various financial roles at Glaxo Inc., including as director of audit and consulting services. She also gained 10 years of public accounting experience with Coopers & Lybrand, specializing in technology and manufacturing. She holds a bachelor's of science degree in accounting and is a certified public accountant.

Luke Roush

Luke Roush is responsible for creating the strategy and managing the execution of TransEnterix's sales and marketing efforts in the US and Europe. He also has responsibility for business development transactions.

Most recently, Roush served as chief operating officer at Liquidia Technologies, a privately held nanotechnology company focused on biopharmaceutical and alternative energy applications.

Roush previously served as global group marketing manager for Boston Scientific’s neurovascular hemorrhagic stroke business, and held sales and marketing roles of increasing responsibility at Newell Rubbermaid, a Fortune 500 company.

Roush graduated summa cum laude from Duke University, and earned his MBA from Duke University’s Fuqua School of Business.